Francisco Rivas

524 citations
35 papers · 271 indexed · h-index 9
Topics
Lung Cancer Diagnosis and Treatment (5 papers)Pleural and Pulmonary Diseases (5 papers)Sympathectomy and Hyperhidrosis Treatments (5 papers)
Partner nations
SpainChile

In The Last Decade

Francisco Rivas

29 papers receiving 260 citations

Peers

Francisco Rivas
Comparison fields: 5 of 42
  • Pulmonary and Respiratory Medicine 156
  • Rheumatology 112
  • Oral Surgery 77
  • Surgery 51
  • Oncology 40
Replace Anna Ureña with:
Anna Ureña Spain
Shimpei Kawaguchi Japan
Kil Dong Kim South Korea
W H Chow China
Du–Young Kang South Korea
Richard Oakley United Kingdom
Kevin Potts United States
J. Valfrey France
E Cislaghi Italy
Sl Juvekar India
Francisco Rivas relative to Anna Ureña Spain Anna Ureña's profile →
Citations per field
00.5×1.5×
Anna Ureña · 1×
Citations per year

Countries citing papers authored by Francisco Rivas

Since Specialization
Citations

This map shows the geographic impact of Francisco Rivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Rivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Rivas more than expected).

Fields of papers citing papers by Francisco Rivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Rivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Rivas. The network helps show where Francisco Rivas may publish in the future.

Co-authorship network of co-authors of Francisco Rivas

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Rivas. A scholar is included among the top collaborators of Francisco Rivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Rivas. Francisco Rivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 8
5 3
6 3
7 1
8 1
9 14
10 1
11 2
12 2
13 41
14 1
15 1
16 9
17 4
18 3
19 0
20 19

About Francisco Rivas

Francisco Rivas is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oral Surgery, having authored 35 papers that have together received 271 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Pleural and Pulmonary Diseases (5 papers) and Sympathectomy and Hyperhidrosis Treatments (5 papers). The work is most often cited by research in Oral Surgery (77 citations), Rheumatology (112 citations) and Pulmonary and Respiratory Medicine (156 citations). Francisco Rivas has collaborated with scholars based in Spain and Chile. Frequent co-authors include Anna Ureña, Iván Macı́a, Ricard Ramos, Ignacio Escobar, R. Villalonga, Juan Moya, Valerio Perna, Cristina Masuet‐Aumatell, Ernest Nadal and Arturo Navarro-Martín. Their work appears in journals such as European Respiratory Journal, Annals of Surgical Oncology and Surgical Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026